바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Next
e-Submission

Vol.77 No.6
Citation Share

Respiratory Review of 2014: Asthma

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2014, v.77 no.6, pp.237-242

(2014). Respiratory Review of 2014: Asthma. Tuberculosis & Respiratory Diseases, 77(6), 237-242.
  • Downloaded
  • Viewed
PDF Download

Abstract

Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatoryphenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. Theintroduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent developmentof new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokinetherapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In thispaper, we will review the major articles related to asthma treatment that were published in 2013.

keywords
Asthma, Eosinophilia, Cytokines, Sublingual Immunotherapy

Reference

1.

1. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368:2455-66.

2.

2. Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 2013;188:1294-302.

3.

3. Laviolette M, Gossage DL, Gauvreau G, Leigh R, Olivenstein R, Katial R, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol 2013;132:1086-96.

4.

4. Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013;309:1278-88.

5.

5. Sadatsafavi M, Lynd L, Marra C, Bedouch P, Fitzgerald M. Comparative outcomes of leukotriene receptor antagonists and long-acting beta-agonists as add-on therapy in asthmatic patients: a population-based study. J Allergy Clin Immunol 2013;132:63-9.

6.

6. Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, et al. Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 2013;132:1295-302.

7.

7. McKeever T, Harrison TW, Hubbard R, Shaw D. Inhaled corticosteroids and the risk of pneumonia in people with asthma:a case-control study. Chest 2013;144:1788-94.

8.

8. Tse SM, Li L, Butler MG, Fung V, Kharbanda EO, Larkin EK, et al. Statin exposure is associated with decreased asthmarelated emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med 2013;188:1076-82.

9.

9. Short PM, Williamson PA, Anderson WJ, Lipworth BJ. Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma. Am J Respir Crit Care Med 2013;187:1308-14.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy